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Background: Complementary traditional Chinese medicine (TCM) has been used to treat patients with cerebral
palsy (CP). However, large-scale surveys examining its use in the treatment of CP and associated disorders are lacking.
Methods: We enrolled 11,218 patients≤ 18 years of age with CP in the Taiwanese National Health Insurance Research
Database from 1995 to 2011. Patients were categorized as TCM users (n = 6,997; 62.37%) and non-TCM users (n = 4,221;
37.63%) based on the inclusion of TCM in their treatment plan.
Results: Children with higher proportions of complementary TCM use were male, younger, and lived in urbanized
areas. Most TCM users (n = 5332, 76.2%) visited TCM outpatient departments more than 20 times per year. In both
groups, the three most common reasons for clinical visits were problems of the nervous system, respiratory system,
and digestive system. Acupuncture was commonly used in problems of injury, musculoskeletal system and connective
tissue, and nervous system. Chinese herbal medicine was used to improve the primary symptoms of CP in patients, as
well as its associated disorders. The incidence rate ratios in allergic rhinitis, dyspepsia, menstrual disorders, and
musculoskeletal system and connective tissue diseases among TCM users were significantly higher than non-TCM
users. Although patients receiving complementary TCM therapies had higher medical expenditure for utilizing
outpatient clinical consultations, their medical costs for visiting ER and hospitalization were significantly lower
than that of non-TCM user within one year of the diagnosis of CP.
Conclusion: This study was a large-scale survey to characterize patterns of complementary TCM use among
children with CP. The complementary use of TCM in children with CP was considerably high. Future clinical
trials and basic researches can be developed based on the findings of this study.
Keywords: Acupuncture, Cerebral palsy, Rehabilitation, Epidemiology, Medical expenditure, National health
insurance research database, Traditional Chinese medicine* Correspondence: tchang0604@yahoo.com.tw
†Equal contributors
3Department of Chinese Medicine, China Medical University Hospital, 2 Yude
Road, North District, Taichung 404, Taiwan
10School of Post-Baccalaureate Chinese Medicine, College of Chinese
Medicine, China Medical University, Taichung, Taiwan
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Liao et al. BMC Complementary and Alternative Medicine  (2017) 17:155 Page 2 of 12Background
Infantile cerebral palsy (CP) refers to a non-progressive
syndrome characterized by hypoxia of the underdevel-
oped brain of infants or children below the age of two
(prenatal or perinatal period), thereby inducing postural
and motor disabilities [1]. There are many causes of CP,
and most cases are believed to be due to prenatal factors.
The most common risk factors for CP are prematurity,
followed by intrauterine growth restriction, intrauterine
infection, antepartum hemorrhage, severe placental path-
ology, and multiple pregnancy [2]. It is the most common
motor disability in childhood with a prevalence of ap-
proximately 2 to 4 cases per 1000 children [3].
Current treatment including physical therapy and occu-
pational therapy plays an important role in treating chil-
dren with CP [4]. In addition to abnormalities of motor
activity and posture, children with CP often have other
disorders of cerebral function, including intellectual dis-
ability or specific learning disabilities, behavioral and emo-
tional disorders, seizures and impaired vision and speech
[5]. Therefore, teams consisting of the family and medical
staff are necessary to maximize children's social and emo-
tional development, communication, education, nutrition,
mobility, and independence in daily activities [6, 7].
The integration of traditional Chinese medicine
(TCM) has been widely practiced in Taiwan. It has been
used to treat various pediatric diseases such as asthma
[8], atopic dermatitis [9], rhinosinusitis [10, 11], diabetes
[12], precocity [13], and cancer [14]. A few clinical [15]
or animal [16] studies have reported treating CP with
TCM, especially by acupuncture. However, there is a
lack of large-scale, population-based, epidemiological
analyses regarding the utilization patterns of comple-
mentary TCM for children with CP.
Since 1995, the majority of the total population in
Taiwan (23 million people) has been enrolled in the
mandatory National Health Insurance (NHI) program
[17]. The practice of TCM has been reimbursed by the
NHI program since 1996. Although the broad definition
of TCM includes Chinese herbal medicine, proprietary
Chinese medicine, acupuncture, moxibustion, manipula-
tion, and Qi management, only the following three major
modalities have been covered: (1) Chinese herbal medicine
manufactured by GMP-certified pharmaceutical compan-
ies (concentrated scientific TCM granules), (2) acupunc-
ture/moxibustion (including acupuncture, moxibustion
and cupping therapy) and (3) Chinese orthopedic trauma-
tology therapy (including manipulative therapy, acupres-
sure, and tuina massage) [18]. All claims data were
collected in the National Health Insurance Research Data-
base (NHIRD).
We investigated the characteristics of adjunctive TCM
use in children with CP by analyzing Taiwan’s NHIRD.
This dataset comprehensively included all children whowere clinically and radiographically confirmed to have
CP with long-term follow-up, thus reducing the poten-
tial for sampling bias. This study was important in set-
ting the foundation for understanding the patterns of
complementary TCM utilization. The results of this
study provided useful information for those involved in
the healthcare of children with CP.
Methods
Data source
Taiwan launched the NHI program in March 1995, and
by 2015, it covered more than 99% of Taiwanese resi-
dents [17]. Since 1995, the NHI program has reimbursed
nearly all of the necessary Western medical services and
included TCM services in 1996. The choice to utilize
TCM or Western medicine belongs to the patient and is
not influenced by the insurer. Only licensed TCM doc-
tors are qualified for reimbursement. The large comput-
erized NHI database (NHIRD; http://nhird.nhri.org.tw/)
was provided by the National Health Insurance Admin-
istration and maintained by the National Health Re-
search Institutes of Taiwan. The registry comprises de-
identified information regarding medical care facilities,
specialties, gender, birth dates, visit dates, prescriptions,
health management, costs and diagnostic codes based on
the International Classification of Disease, 9th Revision,
Clinical Modification (ICD-9-CM). The NHIRD also
established a “registry for catastrophic illnesses patient
database (RCIPD)", which included approximately 30
disease categories such as cancer, schizophrenia, end-
stage renal disease, multiple sclerosis and CP. Cata-
strophic illness certificates were administered to children
with CP who had completed a clinical and neuroimaging
evaluation, followed by a thorough and routine review
by pediatricians or rehabilitation physicians appointed
by the NHI Administration. Thus, the diagnosis of CP in
children participating in this study was highly reliable.
Study subjects and variables
The flow chart for the selection of CP cases is illustrated
in Fig. 1. Of all 23 million enrollees of the NHI program,
patients under the age of 18 (n = 11,218) at the time of
diagnosis of CP (ICD-9-CM code: 343) in the RCIPD of
NHIRD were included in this study. They were then
followed-up until the end of 2011. After an accurate diag-
nosis of CP, the children who consulted with TCM doctors
were grouped as TCM users (n = 6,997), while the others
were grouped as non-TCM users (n = 4,221). The demo-
graphic characteristics and claims data of this study cohort
were collected and analyzed.
The urbanized residential areas of all individuals were
divided into two groups, with urban areas more highly
represented than rural areas. The urbanization of resi-
dential areas has been described previously [19, 20]. In
Fig. 1 Flow recruitment chart of children with cerebral palsy from the registry for catastrophic illnesses patient database (RCIPD) of the Taiwanese
National Health Insurance Research program from 1995 to 2011
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levels of urbanization based on population density
(people/km2), the ratio of the population with varying
educational levels, the ratio of elderly people, the ratio of
agricultural workers, and the number of physicians per
100,000 people. Levels 1 and 2 of this urbanization were
defined as urban areas, while levels 3 and 4 were classi-
fied as rural areas.
The concentrated scientific TCM granules included
TCM herbal formulas and single herbs. Therapeutic ac-
tions and indications of TCM prescriptions were re-
corded based on the TCM theory [21]. The core
prescription patterns were analyzed as described previ-
ously [22, 23]. In brief, an open-sourced freeware
NodeXL (http://nodexl.codeplex.com/) was applied to
investigate the core patterns of Chinese herb medicine
for the treatment of patients with CP, and the most
common two herbal combinations were applied in this
network analysis. The thicker line width, defined as
counts of connections between formulas and herbs, in-
dicated the more significant prescription patterns in the
network.
The medical expenditure of utilizing emergency room
(ER) service, outpatient clinical care and hospitalization
between patients with and without TCM treatment
within one year after CP was diagnosed were calculated
in New Taiwan dollars.Ethics statement
The NHIRD was provided by the National Health Insur-
ance Administration and managed by the National
Health Research Institutes, Taiwan. All of the datasets
were de-identified and encrypted to protect enrollees’
privacy. Therefore, it was not possible to identify indi-
vidual patients in any way. This study was approved bythe Research Ethics Committee of China Medical Uni-
versity and Hospital (CMUH104-REC2-115).
Statistics
The data were analyzed by using SAS software, version
9.2 (SAS Institute Inc., Cary, NC, U.S.A.). We used the
chi-square test to compare categorical variables and the
t-test to compare continuous variables. We estimated
the incidence rate ratio and 95% confidence intervals
(CIs) by using the Poisson regression. A P value <0.05
was defined as statistically significant.
Results
We identified 11,218 patients under the age of 18 who
were diagnosed with infantile CP with catastrophic ill-
ness certificates (Fig. 1). Among these children, 62.37%
(n = 6,997) were TCM users, while 37.63% (n = 4,221)
were not TCM users. Some proportional differences
were found between TCM and non-TCM users in
age, sex, urbanization, and annual outpatient clinical
visits (Table 1). Children with higher proportions of
TCM use were male, younger (age 0–2 and 3–5), and
resided in urbanized areas. Furthermore, most TCM
users (n = 5,332, 76.2%) visited TCM outpatient de-
partments more than 20 times per year. By contrast,
the rate of annual outpatient visits was lower in non-
TCM users than in TCM users. However, it has to be
mentioned that these small differences may not be
clinically significant but may be statistically significant
given the large sample size.
We further analyzed the frequency distribution of
TCM and non-TCM visits by major disease category/
diagnosis in children with CP (Table 2). In both groups,
the three most common causes of clinical visits were
problems of the nervous system (46.6% in TCM users
versus 45.6% in non-TCM users), respiratory system
Table 1 Demographic characteristics between TCM and non-
TCM users among children with cerebral palsy from 1995–2011
TCM user Non-TCM user
N = 6997 N = 4221
N % N % p-value
Sexa 0.008
Girl 2851 40.8 1827 43.3
Boy 4146 59.3 2394 56.7
Agea, year <0.0001
0–2 3086 44.1 1444 34.2
3–5 1845 26.4 896 21.2
6–12 1567 22.4 1281 30.4
13–18 499 7.13 600 14.2
Urbanizationa <0.0001
Urban 4132 59.0 2322 55.0
Rural 2865 41.0 1899 45.0
Annual outpatient clinical visita <0.0001
< 5 113 1.61 318 7.53
5–9 386 5.52 517 12.3
10–19 1166 16.7 1103 26.1
20+ 5332 76.2 2283 54.1
Mean (SD)b 41.5 (28.3) 26.7 (21.2) <0.0001
aChi-square test; bStudent’s t-test
Table 2 Frequency distribution of TCM and non-TCM visits by disea
Disease (ICD-9-CM)
Infectious and parasitic disease (001–139)
Neoplasms (140–239)
Endocrine, nutritional and metabolic disease and immunity disorder (240–27







Complications of pregnancy, childbirth and the puerperium (630–676)
Skin and subcutaneous tissue (680–709)
Musculoskeletal system and connective tissue (710–739)
Congenital anomalies (740–759)
Certain conditions originating in the perinatal period (760–779)
Symptoms, signs and ill-defined conditions (780–799)
Injury and poisoning (800–999)
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and digestive system (6.12% in TCM users versus 6.20%
in non-TCM users).
We also analyzed the complementary TCM treatment
options that the patients received (Table 3). Chinese
herbal medicine was mainly used for treating symptoms
related to nervous system, respiratory system, signs and
ill-defined conditions. Acupuncture was mainly used for
treating problems of injury, musculoskeletal system and
connective tissue disorder, and nervous system. Chinese
orthopedic traumatology was mainly used for symptoms
related to nervous system, mental disorder, and injury.
To identify the prescription patterns of TCM doctors in
treating children with CP, we also analyzed the Chinese
herbal formulas and single herbs prescribed by TCM
doctors (Table 4). The most commonly prescribed
herbal formula was Ma-Zi-Ren-Wan (4.07%), followed
by Liu-Wei-Di-Huang-Wan (3.34%) and Xiang-Sha-
Liu-Jun-Zi-Tang (3.27%). The ten most common single
herb prescribed by TCM doctors was Rhizoma Acori
Graminei (Shi-chang-pu) (2.55%), followed by Radix
et Rhizoma Rhei (Da-huang) (2.39%) and Rhizoma
Gastrodiae (Tian-ma) (2.1%). The core patterns of
Chinese herb medicine for the treatment of patients
with CP included Xin-Yi-Qing-Fei-Tang and Radix
Glycyrrhizae (Gan-cao) as well as Rhizoma Acori Graminei
(Shi-chang-pu), Rhizoma Gastrodiae (Tian-ma) and Radix
Polygalae (Yuan-zhi) (Fig. 2).se categories/diagnosis among children with cerebral palsy





Visits no. % Visits no %
87845 2.73 50181 4.54
3992 0.12 1726 0.16
9) 16310 0.51 5527 0.50
2894 0.09 1208 0.11
195321 6.08 53797 4.87
1496602 46.6 503782 45.6
21600 0.67 5241 0.47
847770 26.4 304833 27.6
196656 6.12 68418 6.20
16555 0.51 5870 0.53
430 0.01 74 0.01
56605 1.76 24637 2.23
30253 0.94 7420 0.67
56202 1.75 20061 1.82
26011 0.81 7171 0.65
102187 3.18 28918 2.62
57416 1.79 15518 1.41
Table 3 Frequency distribution various TCM therapies by major disease categories/diagnosis among children with cerebral palsy
Disease (ICD-9-CM) CHM COT ACU CHM + COT CHM+ ACU CHM+ COT + ACU
Infectious and parasitic disease (001–139) 0.38 0.31 0.10 0.73 0.13 0.35
Neoplasms (140–239) 0.04 0.06 0.05 0.01 0.07 0.04
Endocrine, nutritional and metabolic disease and immunity disorder (240–279) 0.29 0.13 0.00 0.02 0.00 0.21
Blood and blood-forming organs (280–289) 0.13 0.02. 0.00 0.05 0.00 0.08
Mental disorder (290–319) 4.07 7.73 0.21 5.07 0.26 5.21
Nervous system (320–389) 31.3 76.6 22.5 67.6 27.2 47.7
Circulatory system (390–459) 0.96 2.32 1.47 3.45 7.97 1.56
Respiratory system (460–519) 30.6 0.79 0.00 2.88 0.26 18.2
Digestive system (520–579) 11.8 0.45 0.02 1.23 0.13 7.05
Genitourinary system (580–629) 1.51 0.01 0.00 0.11 0.00 0.89
Complications of pregnancy, childbirth and the puerperium (630–676) 0.04 0.06 0.07 0.05 0.00 0.05
Skin and subcutaneous tissue (680–709) 1.82 0.07 0.02 0.05 0.07 1.09
Musculoskeletal system and connective tissue (710–739) 1.53 4.07 26.9 8.80 20.8 3.66
Congenital anomalies (740–759) 0.43 1.50 1.04 1.29 0.78 0.85
Certain conditions originating in the perinatal period (760–779) 0.16 0.51 0.13 0.41 0.00 0.28
Symptoms, signs and ill-defined conditions (780–799) 14.0 0.90 0.47 2.99 0.52 8.59
Injury and poisoning (800–999) 0.90 4.47 47.0 5.25 41.9 4.19
Abbreviations: CHM Chinese herbal medicine, COT Chinese Orthopedic Traumatology, ACU Acupuncture
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often visited TCM clinics due to the four common dis-
eases: allergic rhinitis, dyspepsia, menstrual disorders, and
musculoskeletal system and connective tissue diseases [18].
We further analyzed the prevalence of these four common
diseases between children with CP who were TCM users
and non-TCM users (Table 5). In all four diseases, the pro-
portions of TCM users were significant higher (p < 0.0001)
than non-TCM users. Regarding the medical expenditure,
complementary TCM users had higher medical expend-
iture for utilizing outpatient clinical care. However, their
medical costs for visiting ER and hospitalization were sig-
nificantly lower than that of non-TCM user within one
year of the diagnosis of CP (Table 6).
Discussion
This population-based study characterized complemen-
tary TCM usage among children with cerebral palsy in
Taiwan. In this study, we found that the proportion of
TCM users in children with CP (62.37%) was much
higher than average (22.5%) [18]. Our study was in ac-
cordance with a previous study in which younger chil-
dren with CP used complementary and alternative more
frequently [24]. The lower the age of the child with CP,
the higher the proportion of TCM utilization that was
found. However, this finding was not in agreement with
previous studies in which older children with allergic
disorders were more likely to consult with TCM services
[8–10]. Furthermore, while both TCM users and non-
TCM users exhibited high rates of annual outpatientvisits, TCM users showed a higher proportion than
non-TCM users. Patients with brain damage need
early and comprehensive medical management. In line
with some studies’ reports on the benefits of treating
brain damage or neurological disorders with TCM
methods [15, 25, 26], it was quite common in Taiwan
to use Chinese medicine to treat children with CP.
Compared to other diseases, the utilization of TCM in pa-
tients with CP was much higher [18, 27, 28]. Possible rea-
sons for this difference included the following: (1) parents
desired a variety of ways to help their ill children, (2)
parents’ thought that natural products such as Chinese
herbs generally had fewer side effects for developing
children, and (3) the NHI program covered high-quality
Chinese medical outpatient care for children with CP
[29, 30], ensuring low medical costs for TCM on the
part of the patients.
Children with CP often suffer from other disorders of
cerebral function, such as intellectual disabilities, neuro-
developmental disorders, epilepsy, visual disorders, and
speech and hearing impairments [5]. However, chronic
pulmonary disease is a leading cause of death among
children with severe CP [31]. The causes of pulmonary
disease in these children are recurrent aspiration caused
by gastroesophageal reflux and palatopharyngeal inco-
ordination and restrictive disease due to scoliosis [31].
This may have explained why the three most common
causes of clinical visits for children with CP in both
TCM and non-TCM groups were related to the nervous,
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Fig. 2 The core prescription pattern of Chinese herbal formulas and single herbs for children with cerebral palsy were analyzed through open-sourced
freeware NodeXL. The thicker line width, defined as counts of connections between formulas and herbs, indicated the more significant prescription
patterns in the network
Liao et al. BMC Complementary and Alternative Medicine  (2017) 17:155 Page 8 of 12Therefore, children with CP did not only suffer from
neurological and musculoskeletal disorders, but the ther-
apy for CP was based on patients’ limitations in body
structure and function. While medication and/or surgery
may have helped to reduce spasticity, hyperreflexia, and
clonus, they did not improve weakness and incoordin-
ation [32, 33]. Moreover, it was uncertain whether these
interventions enhanced functional outcomes. Some re-
ports showed that injections of botulinum toxin type A
(BTX A) in combination with physical and occupational




Dyspepsia and other specified disorders of function of stomach 536.8
Disorders of menstruation and other abnormal bleeding from
female genital tract
626
Disease of the musculoskeletal system and connective tissue 710–739
IRR incidence rate ratio in Poisson regression
*** p value < 0.0001but this treatment did not affect associated disorders such
as gastrointestinal and pulmonary dysfunction. Therefore,
patients and parents needed to seek other ways to solve
these problems. Previous studies also found that children
with multiple disabilities chose a wide range of treatments
to complement conventional therapies [24, 36]. This may
have been another reason for high TCM usage in children
with CP.
In Taiwan, the acceptance of acupuncture among chil-
dren is lower than Chinese herbal medicine [18]. Among
the children with CP, we found that many of the patientsusers
TCM user Non-TCM user Compared to non-TCM user
N % N % IRR (95% CI)
3688 52.7 1329 31.5 1.67 (1.57–1.78)***
2452 35.0 864 20.5 1.71 (1.58–1.85)***
600 8.58 215 5.09 1.68 (1.44–1.97)***
5034 72.0 1977 46.8 1.54 (1.46–1.62)***
Table 6 Total medical expenditure for utilizing ER service,
outpatient clinical consultations and hospitalization within one
year of diagnosis of cerebral palsy
Healthcare service TCM user Non-TCM user
Meana SD Meana SD t-test
ER 1671.7 1591.2 1976.1 1990.9 0.002
Outpatient clinical
consultations
1739.4 2267.4 891.8 1327.0 0.03
Hospitalization 33342.7 63914.2 46583.5 80183.7 0.001
aNew Taiwan dollars
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for symptoms related to injury, musculoskeletal system
and connective tissue disorder, mental disorder, and ner-
vous system. The NHI program also fully covered the inte-
grative approaches, including tuina massage (a kind of
Chinese orthopedic traumatology methods), ear acupunc-
ture, scalp acupuncture, and somatic acupuncture together
to aim to improve the quality of life in children with CP
[29]. This provided an option for these children to receive
the acupuncture and Chinese orthopedic traumatology.
Among the most common Chinese herbal medicine
prescribed for children with CP, majority of them were
indicated to treat condition related to the digestive system.
Children with CP often have growth failure, which is
mainly associated with poor nutrition [37] due to inad-
equate intake and gastrointestinal abnormalities [37–41].
More than 90 percent of children with CP have clinically
significant gastrointestinal symptoms such as swallowing
disorders, chronic constipation, regurgitation and/or
vomiting, chronic aspiration, and abdominal pain [41].
Furthermore, poor digestive function could lead to
chronic pulmonary disease, the main cause of death in
these patients [31]. The most commonly prescribed herbal
formula in TCM to relieve constipation due to deficient
fluid in the colon was Ma-zi-ren-wan, also known as
Hemp Seed Pill. In a previous randomized double-blind
study, Ma-zi-ren-wan was shown to be safe and effective
at alleviating functional constipation [42]. One of the
commonly prescribed single herb, Radix et Rhizoma Rhei,
was also a commonly used laxative [43]. Other herbal for-
mulas such as Liu-wei-di-huang-wan was used for im-
proving osteoporosis [44] and Shao-yao-gan-cao-tang for
relieving muscle spasm [45]. Since neurodevelopmental
disorders [46], growth failure [37], orthopedic disorders
[47, 48] and osteopenia [49–52] were commonly associ-
ated disorders in children with CP, it was reasonable that
some of the TCM prescriptions were used for treating
these illness. Another category of TCM prescriptions,
such as Chai-hu-jia-long-gu-mu-li-tang [21], Rhizoma
Acori Graminei [53], Rhizoma Gastrodiae [54] and Radix
Polygalae [55], were used for alleviating spasms and regu-
late the central nervous system. These three herbs were
included in the core patterns of Chinese herb medicinefor the treatment of patients with CP. Children with
CP were also commonly found to have spastic syn-
dromes [56], dyskinetic syndromes [57], epilepsy [5]
and emotional disorders [46]. Various Chinese herbs,
such as Xin-Yi-Qing-Fei-Tang, Ma-Xing-Shi-Gan-Tang,
Bulbus Fritillariae Thunbergii and Semen Armeniacae,
were used for treating respiratory symptoms. Finally,
Radix Astragali was used traditionally to raise Qi and
has been found to modulate immunity [58]. Taken to-
gether, some of the commonly prescribed Chinese
herbs were used to complement one another to im-
prove the main symptoms of CP. Others could help
treat associated disorders that were not improved by
BTX A injection, physical or occupational therapy,
such as gastrointestinal and pulmonary dysfunction.
With regard to the rate of TCM and non-TCM use
among the four common diseases that we previously
found to be prevalent in pediatric TCM users [18],
musculoskeletal system and connective tissue diseases
had the highest ratio in both groups. The main con-
cerns of patients and parents were likely related to
limitations of the body’s structure and function. In all
four diseases, the proportion of TCM use was signifi-
cantly higher (p < 0.0001) than non-TCM use. This
was consistent with our previous study that showed
that the rate of TCM use for these four common dis-
eases was higher in children in Taiwan [18].
Interestingly, although the medical expenditure for vis-
iting outpatient clinics within one year of diagnosis of
CP of complementary TCM user were higher than the
non-TCM users, the medical costs for utilizing ER ser-
vice and hospitalization were significantly lower. Many
parents and policy-makers concerned about the costs of
complementary and alternative medicine for patients
with CP [59, 60]. This study provided some substantial
economic evaluation for the integration of TCM treat-
ment into the clinical healthcare of CP.
Overall, our study provided useful information re-
garding healthcare and epidemiological patterns of
TCM use to treat children with CP. The importance
of this study was based on the following aspects:
First, based on the literature review and our know-
ledge, this study was the first large-scale investigation
of complementary TCM to patients with CP. Second,
this study included all patients below age 18 in the
NHIRD with catastrophic illness certificates of CP.
The potential for selection bias was eliminated. Third,
the NHI system provides low-cost and convenient
medical insurance to nearly all residents in Taiwan.
Under the NHI program, both Western- and Chinese-
based medical resources are very accessible. In 2012,
there were approximately 59,017 Western medical
doctors and 5,556 licensed TCM doctors serving 23
million people in Taiwan. Moreover, 93.7% of Taiwan’s
Liao et al. BMC Complementary and Alternative Medicine  (2017) 17:155 Page 10 of 12medical institutions, including hospitals and clinics,
take part in the NHI program [61].
The present study had several limitations. First, the
NHI system did not reimburse purchases of healthy
foods containing herbal ingredients. Second, we were
unable to estimate treatment efficacy and disease sever-
ity in this study due to the lack of disease severity data
in the NHIRD. Lastly, the neuroscience evidence of acu-
puncture and pharmacological mechanism of Chinese
herbal medicine remained unclear. Therefore, we ex-
pected future studies and clinical trials to investigate the
mechanism and clinical efficacy based on this study.
Conclusion
This study was a large-scale survey to characterize pat-
terns of complementary TCM use among children with
CP. The complementary use of TCM in children with
CP was considerably high. The reasons for patients’ clin-
ical visits were related to their neurodevelopmental and
musculoskeletal disorders, as well as their respiratory
and digestive system problems. Complementary TCM
users had lower medical costs of utilizing ER service and
hospitalization than non-TCM users. Future clinical tri-
als and basic researches could be developed based on
the findings of this study.
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